|
| Dosage Form | : | Film-coated tablets | | Active Ingredients | : | Letrox | | Package Type | : | 2,5 mg film-coated tablet 30 tablet/box | | Licensor | : | Celon Pharma Sp.zo.o. | | Indication Group | : | ANTINEOPLASTIC AGENTS | | | | | |
| Prospectus | : |  |
| |
| Dosage Form | : | Powder for solution for infusion | | Active Ingredients | : | Oxaliplatin | | Package Type | : | 100 mg/20 mL flacon/box (i.v.) | | Licensor | : | Medac Geselschaft für klinische Spezialpraparate mbH, | | Indication Group | : | ANTINEOPLASTIC AGENTS | | | | | |
| Prospectus | : | |
| |
| Dosage Form | : | Powder for solution for infusion | | Active Ingredients | : | Oxaliplatin | | Package Type | : | 50 mg/10 mL flacon/box (i.v.) | | Licensor | : | Medac Geselschaft für klinische Spezialpraparate mbH, | | Indication Group | : | ANTINEOPLASTIC AGENTS | | | | | |
| Prospectus | : | |
| |
|
